Published in Lancet Neurol on March 01, 2010
Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci (2011) 1.71
Pain as a channelopathy. J Clin Invest (2010) 1.33
Pathophysiology of the neurovascular unit: disease cause or consequence? J Cereb Blood Flow Metab (2012) 1.28
Paradoxical air microembolism induces cerebral bioelectrical abnormalities and occasionally headache in patent foramen ovale patients with migraine. J Am Heart Assoc (2012) 0.95
Studies on the pathophysiology and genetic basis of migraine. Curr Genomics (2013) 0.94
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy syndrome mutations increase susceptibility to spreading depression. Ann Neurol (2011) 0.90
Headache: migraine, magnetic stimulation and cortical excitability. Nat Rev Neurol (2010) 0.87
Is spreading depolarization characterized by an abrupt, massive release of gibbs free energy from the human brain cortex? Neuroscientist (2012) 0.85
Risk factors of migraine-related brain white matter hyperintensities: an investigation of 186 patients. J Headache Pain (2011) 0.84
Matrix metalloproteinases in neuropathic pain and migraine: friends, enemies, and therapeutic targets. Pain Res Treat (2012) 0.83
Migraine and risk of stroke in older adults: Northern Manhattan Study. Neurology (2015) 0.79
Prevalence of cardiac right left shunts in migraine: a population-based case-control study. Neurol Sci (2012) 0.79
Migraine with aura: which patients are most at risk of stroke? Neurol Sci (2015) 0.79
Effect of intravenous sodium valproate vs dexamethasone on acute migraine headache: a double blind randomized clinical trial. PLoS One (2015) 0.78
The pulsatility volume index: an indicator of cerebrovascular compliance based on fast magnetic resonance imaging of cardiac and respiratory pulsatility. Philos Trans A Math Phys Eng Sci (2016) 0.77
Migraine as a risk factor for young patients with ischemic stroke: a case-control study. Neurol Sci (2017) 0.76
Duel-acting subcutaneous microemulsion formulation for improved migraine treatment with zolmitriptan and diclofenac: formulation and in vitro-in vivo characterization. AAPS J (2013) 0.75
Secondary headaches: secondary or still primary? J Headache Pain (2012) 0.75
Genetic and biochemical changes of the serotonergic system in migraine pathobiology. J Headache Pain (2017) 0.75
Parenchymal spin-lock fMRI signals associated with cortical spreading depression. J Cereb Blood Flow Metab (2014) 0.75
Cardiac cephalalgia: one case with cortical hypoperfusion in headaches and literature review. J Headache Pain (2017) 0.75
Migraine Modulation and Debut after Percutaneous Atrial Septal Defect Closure: A Review. Front Neurol (2017) 0.75
Towards use of MRI-guided ultrasound for treating cerebral vasospasm. J Ther Ultrasound (2016) 0.75
Visual Field Losses in Patients with Migraine without Aura and Tension-Type Headache. Neuroophthalmology (2017) 0.75
Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med (1994) 8.03
Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci (2003) 6.53
Migraine as a risk factor for subclinical brain lesions. JAMA (2004) 5.02
Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med (2002) 4.86
Cadasil. Lancet Neurol (2009) 3.88
Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A (2001) 3.51
The neurobiology of vascular head pain. Ann Neurol (1984) 2.89
Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ (2004) 2.86
Migraine headache in middle age and late-life brain infarcts. JAMA (2009) 2.65
Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain (2005) 2.59
Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ (2008) 2.48
Migraine frequency and risk of cardiovascular disease in women. Neurology (2009) 2.47
Decreased number and function of endothelial progenitor cells in patients with migraine. Neurology (2008) 2.44
Probable migraine with visual aura and risk of ischemic stroke: the stroke prevention in young women study. Stroke (2007) 2.43
Ischemic stroke and active migraine. Neurology (2001) 2.34
Migraine and other headaches: associations with Rose angina and coronary heart disease. Neurology (2004) 2.32
Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology (2005) 2.31
Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain (2006) 2.29
The natural history of CADASIL: a pooled analysis of previously published cases. Stroke (1999) 2.14
Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol (1981) 2.03
Migraine, headache, and the risk of stroke in women: a prospective study. Neurology (2005) 2.01
Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet (2000) 1.99
Migraine and risk of ischaemic stroke: a case-control study. BMJ (1993) 1.79
Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation (2008) 1.77
Cortical spreading depression and peri-infarct depolarization in acutely injured human cerebral cortex. Brain (2005) 1.74
Migraine and retinal microvascular abnormalities: the Atherosclerosis Risk in Communities Study. Neurology (2007) 1.73
A controlled study of ischemic stroke risk in migraine patients. J Clin Epidemiol (1989) 1.71
Vascular smooth muscle cell dysfunction in patients with migraine. Neurology (2009) 1.71
Spreading and synchronous depressions of cortical activity in acutely injured human brain. Stroke (2002) 1.55
Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke (1998) 1.52
Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study. Neurology (1998) 1.51
Improvement of migraine after patent foramen ovale percutaneous closure in patients with subclinical brain lesions: a case-control study. JACC Cardiovasc Interv (2009) 1.50
Platelet aggregability in migraine. Neurology (1977) 1.46
Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol (2010) 1.45
Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia (2008) 1.45
Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain (1993) 1.42
Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol (1983) 1.36
Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis. Circulation (1989) 1.35
New roles for the major human 3'-5' exonuclease TREX1 in human disease. Cell Cycle (2008) 1.35
Brain stem and cerebellar hyperintense lesions in migraine. Stroke (2006) 1.34
Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry (2002) 1.32
Endothelin-1 potently induces Leão's cortical spreading depression in vivo in the rat: a model for an endothelial trigger of migrainous aura? Brain (2002) 1.30
Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci (1994) 1.22
Magnetoencephalographic fields from patients with spontaneous and induced migraine aura. Ann Neurol (2001) 1.21
Impaired cerebral vasoreactivity in a transgenic mouse model of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy arteriopathy. Stroke (2005) 1.14
Clinical implications of migraine in systemic lupus erythematosus: relation to cumulative organ damage. Cephalalgia (2004) 1.13
Deciphering migraine mechanisms: clues from familial hemiplegic migraine genotypes. Ann Neurol (2004) 1.12
Migraine and ischaemic heart disease and stroke: potential mechanisms and treatment implications. Cephalalgia (2007) 1.12
Migraine and the risk of cervical artery dissection: a case-control study. Neurology (2002) 1.11
The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Med (2004) 1.10
Hypoxia and hypotension transform the blood flow response to cortical spreading depression from hyperemia into hypoperfusion in the rat. J Cereb Blood Flow Metab (2008) 1.06
Increased von Willebrand factor in migraine. Neurology (2001) 1.05
Reduced cerebrovascular CO(2) reactivity in CADASIL: A transcranial Doppler sonography study. Stroke (2001) 1.04
Patent foramen ovale and cerebrovascular diseases. Nat Clin Pract Cardiovasc Med (2006) 1.04
Migraine with aura-like headache associated with moyamoya disease. Acta Neurol Scand (1999) 1.01
Positron emission tomography examination of cerebral blood flow and glucose metabolism in young CADASIL patients. Stroke (2004) 0.93
Enhanced spontaneous thrombolysis: a new therapeutic challenge. J Thromb Thrombolysis (2006) 0.93
Mitochondrial inhibition prior to oxygen-withdrawal facilitates the occurrence of hypoxia-induced spreading depression in rat hippocampal slices. J Neurophysiol (2006) 0.93
Increased prevalence of migraine and chest pain in patients with primary Raynaud disease. Ann Intern Med (1992) 0.93
A pulmonary right-to-left shunt in patients with hereditary hemorrhagic telangiectasia is associated with an increased prevalence of migraine. Chest (2005) 0.93
Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia (2009) 0.92
Associations between migraine and cardiovascular disease. Expert Rev Neurother (2007) 0.92
Platelet-leukocyte interaction and platelet activation in migraine: a link to ischemic stroke? J Neurol Neurosurg Psychiatry (2004) 0.90
Prevalence of migraine and Raynaud's phenomenon in Japanese patients with vasospastic angina. Jpn Circ J (2000) 0.90
Re-evaluation of the relationship between migraine and persistent foramen ovale and other right-to-left shunts. Clin Sci (Lond) (2005) 0.87
Migraine and patent foramen ovale: connecting flight or one-way ticket? Expert Rev Neurother (2008) 0.87
Images in clinical medicine. Paradoxical embolism--thrombus in transit through a patent foramen ovale. N Engl J Med (1997) 0.85
Diffusion MRI during migraine with aura attack associated with diagnostic microbubbles injection in subjects with large PFO. Headache (2007) 0.83
Cranial and peripheral interictal vascular changes in migraine patients. Cephalalgia (2003) 0.83
Multiparametric monitoring of the awake brain exposed to carbon monoxide. J Appl Physiol (1985) (1995) 0.83
Livedo reticularis and migraine: a marker for stroke risk? Headache (2002) 0.81
Migraine with aura induced by artificial microbubbles. Cephalalgia (2008) 0.80
Increased levels of plasma von Willebrand factor in migraine crisis. Acta Neurol Scand (1995) 0.80
Mechanism of spreading depression: a review of recent findings and a hypothesis. Can J Physiol Pharmacol (1992) 0.80
A study of headaches and migraine in Sjögren's syndrome and other rheumatic disorders. Ann Rheum Dis (1989) 0.78
The 3p21.1-p21.3 hereditary vascular retinopathy locus increases the risk for Raynaud's phenomenon and migraine. Cephalalgia (2005) 0.78
Characteristic features of in vivo skin microvascular reactivity in CADASIL. J Cereb Blood Flow Metab (2006) 0.77
Transient in vivo membrane depolarization and glutamate release before anoxic depolarization in rat striatum. Brain Res (1999) 0.77
Differing mechanisms between posterior and middle cerebral artery infarctions. J Stroke Cerebrovasc Dis (2007) 0.76
Symptomatic migraine linked to stroke due to paradoxical embolism and elevated thrombosis risk. Cephalalgia (2002) 0.76
Migraine and antiphospholipid antibodies: no association found in migraine-discordant monozygotic twins. Cephalalgia (2008) 0.76
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol (2005) 11.63
Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci (2003) 6.53
Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med (2002) 4.86
Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc Natl Acad Sci U S A (2005) 4.63
Myocardial infarction accelerates atherosclerosis. Nature (2012) 4.48
Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med (2002) 3.17
Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J Exp Med (2012) 2.92
Simultaneous imaging of total cerebral hemoglobin concentration, oxygenation, and blood flow during functional activation. Opt Lett (2003) 2.70
Laser speckle flowmetry for the study of cerebrovascular physiology in normal and ischemic mouse cortex. J Cereb Blood Flow Metab (2004) 2.59
Vasoconstrictive neurovascular coupling during focal ischemic depolarizations. J Cereb Blood Flow Metab (2005) 2.32
Early release of HMGB-1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab (2007) 2.31
Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol (2006) 2.25
Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke (2005) 2.13
Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab (2008) 2.06
Cortical spreading depression activates and upregulates MMP-9. J Clin Invest (2004) 1.93
Normobaric hyperoxia improves cerebral blood flow and oxygenation, and inhibits peri-infarct depolarizations in experimental focal ischaemia. Brain (2007) 1.92
Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase. Proc Natl Acad Sci U S A (2008) 1.91
Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J Clin Invest (2008) 1.81
Rapid nongenomic actions of thyroid hormone. Proc Natl Acad Sci U S A (2006) 1.79
Pathophysiology of migraine. Annu Rev Physiol (2012) 1.73
Exciting, radical, suicidal: how brain cells die after stroke. Stroke (2005) 1.68
The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. J Clin Invest (2007) 1.67
Stroke program review group: an interim report. Stroke (2008) 1.67
Targeting eNOS for stroke protection. Trends Neurosci (2004) 1.60
Mild induced hypertension improves blood flow and oxygen metabolism in transient focal cerebral ischemia. Stroke (2008) 1.58
Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain (2007) 1.55
Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. J Neurol Sci (2005) 1.54
Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms. Circulation (2007) 1.53
Migraine as an inflammatory disorder. Neurology (2005) 1.53
tPA and proteolysis in the neurovascular unit. Stroke (2004) 1.47
Simultaneous multispectral reflectance imaging and laser speckle flowmetry of cerebral blood flow and oxygen metabolism in focal cerebral ischemia. J Biomed Opt (2008) 1.46
EGF amplifies the replacement of parvalbumin-expressing striatal interneurons after ischemia. J Clin Invest (2003) 1.45
Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol (2010) 1.45
Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders. J Neurochem (2003) 1.44
Obesity increases vascular senescence and susceptibility to ischemic injury through chronic activation of Akt and mTOR. Sci Signal (2009) 1.43
Sphingosine-1-phosphate induces proliferation and morphological changes of neural progenitor cells. J Neurochem (2004) 1.41
Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ T cells. J Immunol (2003) 1.40
Nuclear translocation of apoptosis-inducing factor after focal cerebral ischemia. J Cereb Blood Flow Metab (2004) 1.40
Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J Clin Invest (2002) 1.40
Caspase activation and neuroprotection in caspase-3- deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc Natl Acad Sci U S A (2002) 1.36
Traumatic brain injury in mice deficient in Bid: effects on histopathology and functional outcome. J Cereb Blood Flow Metab (2006) 1.34
Rho-kinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanisms. J Cereb Blood Flow Metab (2006) 1.32
High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia. Stroke (2010) 1.30
Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations. Circulation (2011) 1.28
Pronounced hypoperfusion during spreading depression in mouse cortex. J Cereb Blood Flow Metab (2004) 1.28
Linking Notch signaling to ischemic stroke. Proc Natl Acad Sci U S A (2008) 1.28
Acute plasmalemma permeability and protracted clearance of injured cells after controlled cortical impact in mice. J Cereb Blood Flow Metab (2007) 1.27
Cell biology. PARP-1--a perpetrator of apoptotic cell death? Science (2002) 1.26
FGF-2 regulates neurogenesis and degeneration in the dentate gyrus after traumatic brain injury in mice. J Clin Invest (2003) 1.24
Regenerative response in ischemic brain restricted by p21cip1/waf1. J Exp Med (2004) 1.22
Sonic hedgehog regulates ischemia/hypoxia-induced neural progenitor proliferation. Stroke (2009) 1.21
Rapid cerebral ischemic preconditioning in mice deficient in endothelial and neuronal nitric oxide synthases. Stroke (2003) 1.19
Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. J Cereb Blood Flow Metab (2005) 1.18
Sonic hedgehog inversely regulates the expression of angiopoietin-1 and angiopoietin-2 in fibroblasts. Int J Mol Med (2007) 1.16
S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate. Eur J Pharmacol (2003) 1.16
Upregulation of the Fas receptor death-inducing signaling complex after traumatic brain injury in mice and humans. J Neurosci (2002) 1.15
Mechanisms of pain modulation in chronic syndromes. Neurology (2002) 1.13
New insights into migraine pathophysiology. Curr Opin Neurol (2006) 1.09
Hypomorphic Notch 3 alleles link Notch signaling to ischemic cerebral small-vessel disease. Proc Natl Acad Sci U S A (2011) 1.08
STAT1 is activated in neurons after ischemia and contributes to ischemic brain injury. J Cereb Blood Flow Metab (2002) 1.08
Enhanced subcortical spreading depression in familial hemiplegic migraine type 1 mutant mice. J Neurosci (2011) 1.07
Hypoxia and hypotension transform the blood flow response to cortical spreading depression from hyperemia into hypoperfusion in the rat. J Cereb Blood Flow Metab (2008) 1.06
Connectivity alterations assessed by combining fMRI and MR-compatible hand robots in chronic stroke. Neuroimage (2009) 1.05
The impact of anesthetics and hyperoxia on cortical spreading depression. Exp Neurol (2008) 1.05
Additive effects of statin and dipyridamole on cerebral blood flow and stroke protection. J Cereb Blood Flow Metab (2008) 1.00
The challenge of connecting the dots in the B.R.A.I.N. Neuron (2013) 0.99
Perfusion pressure-dependent recovery of cortical spreading depression is independent of tissue oxygenation over a wide physiologic range. J Cereb Blood Flow Metab (2010) 0.98
The pathophysiology of migraine: year 2005. J Headache Pain (2005) 0.98
Nitric oxide: considerations for the treatment of ischemic stroke. J Cereb Blood Flow Metab (2012) 0.97
MR contrast probes that trace gene transcripts for cerebral ischemia in live animals. FASEB J (2007) 0.97
Inhibition of cerebral vasoconstriction by dantrolene and nimodipine. Neurocrit Care (2008) 0.96
Recommendations of the National Heart, Lung, and Blood Institute working group on cerebrovascular biology and disease. Stroke (2006) 0.96
Context dependent neuroprotective properties of prion protein (PrP). Prion (2009) 0.95
Blood vessels, migraine, and stroke. Stroke (2007) 0.95
p27Kip1 constrains proliferation of neural progenitor cells in adult brain under homeostatic and ischemic conditions. Stem Cells (2009) 0.94
Androgenic suppression of spreading depression in familial hemiplegic migraine type 1 mutant mice. Ann Neurol (2009) 0.93
Therapeutic implications of central and peripheral neurologic mechanisms in migraine. Neurology (2003) 0.92
Animal models of migraine headache and aura. Curr Opin Neurol (2008) 0.91
Effect of basic fibroblast growth factor treatment on brain progenitor cells after permanent focal ischemia in rats. Stroke (2003) 0.91
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy syndrome mutations increase susceptibility to spreading depression. Ann Neurol (2011) 0.90
Striatal neurons expressing full-length mutant huntingtin exhibit decreased N-cadherin and altered neuritogenesis. Hum Mol Genet (2011) 0.89
Sodium sulfide prevents water diffusion abnormality in the brain and improves long term outcome after cardiac arrest in mice. Resuscitation (2012) 0.89
Nuclear factor-kappaB as a molecular target for migraine therapy. Ann Neurol (2002) 0.89
Recognition memory impairments after subcortical white matter stroke in mice. Stroke (2014) 0.86
Expression of cellular FLICE inhibitory proteins (cFLIP) in normal and traumatic murine and human cerebral cortex. J Cereb Blood Flow Metab (2005) 0.85
Cortical spreading depression and estrogen. Headache (2007) 0.85
Soluble guanylate cyclase alpha1beta1 limits stroke size and attenuates neurological injury. Stroke (2010) 0.84
Cortical spreading depression confounds concentration-dependent pial arteriolar dilation during N-methyl-D-aspartate superfusion. Am J Physiol Heart Circ Physiol (2005) 0.83
Evidence for time-dependent maximum increase of free radical damage and eicosanoid formation in the brain as related to duration of cardiac arrest and cardio-pulmonary resuscitation. Free Radic Res (2003) 0.83
Function of BID -- a molecule of the bcl-2 family -- in ischemic cell death in the brain. Eur Surg Res (2002) 0.83
Mild hypothermia improves survival after prolonged, traumatic hemorrhagic shock in pigs. J Trauma (2005) 0.83
Rac1 is a critical mediator of endothelium-derived neurotrophic activity. Sci Signal (2009) 0.83
Neurotrophin-3 promotes cell death induced in cerebral ischemia, oxygen-glucose deprivation, and oxidative stress: possible involvement of oxygen free radicals. Neurobiol Dis (2002) 0.82
Advances in stroke neuroprotection: hyperoxia and beyond. Neuroimaging Clin N Am (2005) 0.82
Statin potentiates human platelet eNOS activity without enhancing eNOS mRNA and protein levels. Cerebrovasc Dis (2008) 0.81
Functional MRI of Rehabilitation in Chronic Stroke Patients Using Novel MR-Compatible Hand Robots. Open Neuroimag J (2008) 0.81
The dynamics of statins: from event prevention to neuroprotection. Stroke (2006) 0.81
Lipid-sugar particles for intracranial drug delivery: safety and biocompatibility. Brain Res (2002) 0.81
fMRI of delayed albumin treatment during stroke recovery in rats: implication for fast neuronal habituation in recovering brains. J Cereb Blood Flow Metab (2006) 0.81